• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Lumiradx Ltd (NQ: LMDX )

    N/A UNCHANGED
    Last Price Updated: 4:00 PM EST, Jan 8, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Lumiradx Ltd

    < Previous 1 2 3 4 5 6 7 Next >
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Gainers BiondVax Pharmaceuticals (NASDAQ:BVXV) stock increased by 26.3% to $1.73 during Thursday's regular session. The current volume of 55.2 million shares is 5751.8... 
    Via Benzinga
    Surging Omicron-Related Cases Lift LumiraDx Q4 Sales, Expects Sequentially Flat Q1 FY22 Sales
    LumiraDx Limited's (NASDAQ: LMDX) Q4 FY21 sales increased 5.3% Y/Y to $118.3 million, surpassing the consensus of $69.6 million. SARS-CoV-2 Antigen test strips... 
    Via Benzinga
    Earnings Scheduled For March 10, 2022
    Companies Reporting Before The Bell • Despegar.com (NYSE:DESP) is expected to report quarterly loss at $0.08 per share on revenue of $110.93 million. • ProShares... 
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
    Gainers Provention Bio (NASDAQ:PRVB) stoc... 
    Via Benzinga
    The Daily Biotech Pulse: Bausch Files For Eye Health Unit IPO, LumiraDx Antigen Test Can Detect Omicron, Molecular Partners Discloses Fund Stake
    Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Corvus Says Chinese Angel Pharma Starts Phase 1/2 Blood Cancer Study Corvus... 
    Via Benzinga
    Why Are LumiraDx Shares Trading Higher Today?
    LumiraDx (NASDAQ:LMDX) has 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Tuesday
    During Tuesday's trading, 98 companies set new 52-week lows. Intriguing Points From Today's 52-Week Lows And Highs: JPMorgan Chase (NYSE:JPM) was the... 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Monday
    On Monday morning, 66 companies achieved new lows for the year. Noteable 52-Week Lows: Gilead Sciences (NASDAQ:GILD) was the largest firm on a market cap basis to set a... 
    Via Benzinga
    Free COVID Tests: What Stocks Will Benefit?
    The government hasn’t announced yet what company or companies it will be buying from, but there are several businesses involved in producing these kits. 
    Via Talk Markets
    52 Biggest Movers From Yesterday
    Gainers BioDelivery Sciences International, Inc. (NASDAQ: BDSI) shares climbed 52.8% to close at $5.56 on Monday. Collegium Pharmaceutical will acquire BioDelivery Sciences... 
    Via Benzinga
    FDA Reissues Emergency Use Authorization For LumiraDx's COVID-19 Testing Solution
    The FDA has reissued Emergency Use Authorization (EUA) to LumiraDx Ltd's (NASDAQ: LMDX) SARS-CoV-2 RNA STAR Complete, a rapid nucleic acid amplification... 
    Via Benzinga
    Exposures COVID-19 Product Safety
    Earnings Scheduled For November 10, 2021
    Companies Reporting Before The Bell • LumiraDx (NASDAQ:LMDX) is projected to report quarterly loss at $0.24 per share on revenue of $94.32 million. • IsoPlexis (... 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For November 15, 2021
    Upgrades For Targa Resources Corp (NYSE: 
    Via Benzinga
    The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US
    Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus SAB Spikes On Analyst Action SAB Biotherapeutics, Inc. (NASDAQ: SABS) shares... 
    Via Benzinga
    Exposures COVID-19
    The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance
    Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus MorphoSys COO To Leave To Pursue Other Opportunities MorphoSys AG (NASDAQ:... 
    Via Benzinga
    Exposures COVID-19
    Benzinga's Top Ratings Upgrades, Downgrades For October 25, 2021
    Upgrades According to Wedbush, the prior rating for Regions Financial Corp (NYSE: 
    Via Benzinga
    26 Stocks Moving in Friday's Pre-Market Session
    Gainers Phunware, Inc. (NASDAQ: PHUN) rose 300% to $6.10 in pre-market trading. Phunware shares jumped over 45% on Thursday, possibly in sympathy with Digital World Acquisition... 
    Via Benzinga
    The Daily Biotech Pulse: Novavax Retreats Amid Vaccine Issues, LumiraDx COVID Test Approved In India, Sesen Shines On Positive Bladder Cancer Review
    Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Novavax Shares React to Reports Of Manufacturing Issues With Its COVID-19... 
    Via Benzinga
    The Week In SPAC News - Sunday, Oct. 3
    In SPAC news this week, Amicus Therapeutics announced its intent to sell its gene therapy unit to ARYA Sciences Acquisition Corp IV, a SPAC sponsored by Perceptive Advisors. 
    Via Talk Markets
    The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc... 
    Via Benzinga
    The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) Bicycle Therapeutics plc (... 
    Via Benzinga
    The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO
    Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks... 
    Via Benzinga
    Exposures Product Safety
    LumiraDx to Become Publicly Traded following Successful Closing of Merger with CA Healthcare Acquisition Corp.
    From CA Healthcare Acquisition Corp.
    Via Business Wire
    < Previous 1 2 3 4 5 6 7 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.